Lunai Bioworks Inc. Earnings Per Share (Diluted)
Lunai Bioworks Inc. (LNAI) reported Earnings Per Share (Diluted) of -$0.10 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-05-15
- Lunai Bioworks Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.10.
- Lunai Bioworks Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.08.
- Lunai Bioworks Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.13.
- Lunai Bioworks Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.21.
- Lunai Bioworks Inc. earnings per share, diluted for fiscal 2025 was -$1.08.
- Lunai Bioworks Inc. earnings per share, diluted for fiscal 2024 was -$0.91.
- Lunai Bioworks Inc. earnings per share, diluted for fiscal 2023 was -$0.71.
- Lunai Bioworks Inc. earnings per share, diluted for fiscal 2022 was -$2.16.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$0.10 10-Q · filed 2026-05-15 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.07 10-Q · filed 2026-05-15 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2025-12-31 | -$0.08 10-Q · filed 2026-02-17 | $0.04 10-Q · filed 2026-02-17 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2025-09-30 | $0.13 10-Q · filed 2025-11-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2025-06-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.08 10-K · filed 2025-09-29 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$3.18 10-Q · filed 2026-05-15 | -$0.32 10-Q · filed 2025-05-15 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-05-15 | |||
| 2024-12-31 | -$0.45 10-Q · filed 2026-02-17 | -$0.04 10-Q · filed 2025-02-19 | -$3.20 10-Q · filed 2026-02-17 | -$0.32 10-Q · filed 2025-02-19 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.73 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2024-09-30 | -$2.76 10-Q · filed 2025-11-14 | -$0.28 10-Q · filed 2024-11-14 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-05-15 | |||
| 2024-06-30 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$0.57 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$0.73 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$0.91 10-K · filed 2025-09-29 | -$0.84 10-K · filed 2024-10-10 | |||
| 2024-03-31 | -$0.54 10-Q · filed 2025-05-15 | -$0.16 10-Q · filed 2024-05-15 | -$0.73 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.91 10-Q · filed 2025-05-15 | -$0.39 10-Q · filed 2024-05-15 | -$1.29 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||
| 2023-12-31 | -$0.07 10-Q · filed 2025-02-19 | -$0.21 10-Q · filed 2025-02-19 | -$0.59 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.67 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-09-30 | -$0.14 10-Q/A · filed 2025-02-19 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.62 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.70 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-06-30 | -$0.40 derived: net income ÷ weighted average shares · filed 2025-02-19 | -$0.48 derived: net income ÷ weighted average shares · filed 2025-02-19 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-02-19 | -$0.71 10-K/A · filed 2025-02-19 | ||||
| 2023-03-31 | -$0.08 10-Q/A · filed 2025-02-19 | -$0.16 derived: net income ÷ weighted average shares · filed 2025-02-19 | -$0.30 10-Q/A · filed 2025-02-19 | |||||
| 2022-12-31 | -$0.08 10-Q · filed 2024-02-14 | -$0.22 10-Q · filed 2024-02-14 | ||||||
| 2022-09-30 | -$0.14 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | -$2.16 10-K · filed 2023-10-02 | |||||||
| 2015-03-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-05-13 | |||||||
| 2014-03-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |